Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $222.2 million.

  • Select Medical Holdings' Capital Expenditures rose 477.28% to $53.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $222.5 million, marking a year-over-year increase of 381.16%. This contributed to the annual value of $222.2 million for FY2024, which is 306.41% down from last year.
  • Per Select Medical Holdings' latest filing, its Capital Expenditures stood at $222.2 million for FY2024, which was down 306.41% from $229.2 million recorded in FY2023.
  • Over the past 5 years, Select Medical Holdings' Capital Expenditures peaked at $229.2 million during FY2023, and registered a low of $146.4 million during FY2020.
  • Moreover, its 5-year median value for Capital Expenditures was $190.4 million (2022), whereas its average is $193.7 million.
  • Per our database at Business Quant, Select Medical Holdings' Capital Expenditures plummeted by 680.09% in 2020 and then skyrocketed by 2328.39% in 2021.
  • Select Medical Holdings' Capital Expenditures (Annual) stood at $146.4 million in 2020, then grew by 23.28% to $180.5 million in 2021, then increased by 5.45% to $190.4 million in 2022, then rose by 20.4% to $229.2 million in 2023, then fell by 3.06% to $222.2 million in 2024.
  • Its Capital Expenditures stands at $222.2 million for FY2024, versus $229.2 million for FY2023 and $190.4 million for FY2022.